THE FIRM TO TRUST

WHEN YOU NEED TO WIN

$150,000,000
In Verdicts And Settlements

Over
81 YEARS
Combined Legal Experience

2000+
Cases Resolved

Research shows drug may reduce severity of traumatic brain injury

| Dec 21, 2016 | Brain Injury

A severe traumatic brain injury can be devastating, leading to disability, personality change and even death. But, even a mild traumatic brain injury can have significant long-term consequences. One of the risks of brain injury is brain cell swelling, which occurs after a brain injury and can worsen the injury. Montana readers may be interested to learn that scientists have discovered that a drug currently used to treat epilepsy can reduce the likelihood and severity of post-TBI brain cell swelling.

Researchers at the University of Arkansas conducted a study of the effects on brain swelling of the antiepileptic drug Acetazolamide, or AZT. They found that AZT inhibits production of a protein associated with brain cell swelling.

Traumatic brain injuries often result from car accidents. Unfortunately, a significant number of TBIs go undetected and are not treated in emergency rooms. Anyone who has been in a car accident and struck their head on the dashboard, steering wheel or other object, or who suspects they received a head injury from airbag deployment, should seek emergency medical treatment right away.

Those who have suffered a concussion or other brain injury in a car accident may also wish to investigate their legal options. If the accident was caused by a negligent driver, the victim may be able to recover damages in a personal injury claim. The victim may be able to seek compensation for medical expenses, lost wages, loss of future earning capacity, scarring, disfigurement, loss of enjoyment of life and pain and suffering.

Source: Digitaljournal.com, “Traumatic brain injury promised pharmaceutical treatment,” Karen Hardison, Dec. 8, 2016

Archives